SCIENCE & ARTICLES
What sparked the inception of SpermaBlock™
For decades, male contraception lagged behind. Hormonal pills for women reshaped medicine, but at the cost of metabolic, vascular and emotional side effects. Men, on the other hand, were offered little innovation.
At Naxon, our research team, composed of surgeons, biomedical engineers and reproductive-health experts, set out to change this paradigm. We designed SpermaBlock™, a reversible, device-based male contraceptive, grounded in rigorous anatomical and physiological science. Unlike hormonal or thermal approaches, SpermaBlock™ acts locally, mechanically, and reversibly, avoiding systemic hormonal disruption and preserving libido, fertility, and overall health.
The articles below summarize the evidence that inspired this breakthrough, understanding the risks of current female contraception, exploring ongoing male solutions, and reviewing vasectomy outcomes.